Intuitive Surgical, Inc. vs Revvity Inc — how do they compare? Intuitive Surgical, Inc. trades at $357.67 (market cap $125.08B), while Revvity Inc trades at $109.4 (market cap $11.87B). The key difference: Intuitive Surgical, Inc. is far larger — about 10.5× Revvity Inc's market cap, and Revvity Inc pays a 0.26% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals.
| ISRG | RVTY | |
|---|---|---|
Market Cap | $125.08B | $11.87B |
Sector | Health | Technology |
52-Week High | $592.85 | $117.75 |
52-Week Low | $345.42 | $82.26 |
Enterprise Value | $116.45B | $14.36B |
Dividend Yield | — | 0.26% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $106.44, down 3.37% today, but maintains a bullish technical outlook with strong analyst support. The company has consistently beaten earnings estimates for three consecutive quarters, with Q2 2026 results expected on August 4, 2026. Recent developments include AI integration partnerships and FDA clearances, supporting growth in its diagnostics and life sciences segments. Valuation metrics show a P/E of 52.96 and P/S of 4.35, reflecting premium pricing for its growth prospects.
The stock presents a balanced opportunity with analyst consensus pointing to 4.7% upside to the $111.43 price target. Strong institutional ownership and zero sell ratings indicate confidence, though high valuation multiples and negative cash flow trends pose risks. Earnings momentum from recent beats and strategic AI expansions provide catalysts, but investors should monitor margin pressures and China market exposure highlighted in recent quarters.
Trailing returns across standard periods
Latest headlines on both assets
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →